Identification of a novel gene underlying familial spastic...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S091200, C536S023100, C536S024300

Reexamination Certificate

active

07811762

ABSTRACT:
Methods of identifying polymorphisms associated with hereditary spastic paraplegia (SPG), are described. The polymorphisms associated with SPG include specific mutations in the receptor expression enhancing protein 1 (REEP1) gene. Also described are methods of diagnosis of SPG.

REFERENCES:
patent: 6924126 (2005-08-01), Weissenbach et al.
patent: 7108925 (2006-09-01), Campbell
patent: 2003/0224968 (2003-12-01), Fink et al.
patent: 2005/0266479 (2005-12-01), Weissenbach et al.
patent: 2006/0057640 (2006-03-01), Matsunami et al.
patent: 2006/0073478 (2006-04-01), Fink et al.
patent: 2007/0015202 (2007-01-01), Fink et al.
Ashley-Koch, A., et al., “Fine Mapping and Genetic Heterogeneity in the Pure Form of Autosomal Dominant Familial Spastic Paraplegia,”Neurogenetics, 3:91-97 (2001).
Evans, K., et al., “Interaction of Two Hereditary Spastic Paraplegia Gene Products, Spastin and Atlastin, Suggests a Common Pathway for Axonal Maintenance,”PNAS, 103:10666-10671 (2006).
Fink, J.K., et al., “Hereditary Spastic Paragplegia: Genetic Heterogeneity and Genotype-Phenotype Correlation,”Seminars in Neurology, 19:301-309 (1999).
Fortini, D., et al., “Current Insights Into Familial Spastic Paraparesis: New Advances in an Old Disease,”Functional Neurology, 18:43-49 (2003).
Hansen, J.J., et al., “Hereditary Spastic Paraplegia SPG13 is Associated with a Mutation in the Gene Encoding the Mitochondrial Chaperonin Hsp60,”Am. J. Hum. Genet., 70:1328-1332 (2002).
Hazan, J. et al., “Spastin, a New AAA Protein, is Altered in the Most Frequent Form of Autosomal Dominant Spastic Paraplegia,”Nat. Genet. 23:296-303 (1999).
Hentati, A., et al. “Linkage of a Locus for Autosomal Dominant Familial Spastic Paraplegia to Chromosome 2p Markers,”Human Molecular Genetics, 3:1867-1871 (1994).
Hiltunen, M., et al., “Butyrylcholinesterase K. Variant and Apolipoprotein E4 Genes to Not Act in Synergy in Finnish Late-Onset Alzheimer's Disease Patients,”Neuroscience Letters, 250:69-71 (1998).
Ishikawa, K. et al., “An Autosomal Dominant Cerebellar Ataxia Linked to Chromosome 16q22.1 Is Associated with A Single-Nucleotide Substitution in the 5′ Untranslated Region of the Gene Encoding a Protein Spectrin Repeat and Rho Guanine-Nucleotide Exchange-Factor Domains,”Am. J. Hum. Genet. 77:280-296 (2005).
Orlacchio, A., “New Locus for Hereditary Spastic Paraplegia Maps to Chromosome 1p31.1-1p21.1,”Ann. Neurol. 58:423-429 (2005).
Raskind, W.H., et al., “Familial Spastic Paraparesis: Evaluation of Locus Heterogeneity, Anticipation, and Haplotype Mapping of the SPG4 Locus on the Short Arm of Chromosome 2,”Am. J. Med. Genet., 74:26-36 (1997).
Reid, E., et al., A Kinesin Heavy Chain (KIF5A) Mutation in Hereditary Spastic Paraplegia (SPG10),Am. J. Hum. Genet. 71:1189-1194 (2002).
Reid, E., et al., “A New locus for Autosomal Dominant “Pure” Hereditary Spastic Paraplegia Mapping to Chromosome 12q13, and Evidence for Further Genetic Heterogeneity,”Am. J. Hum. Genet. 65:757-763 (1999).
Reid, E., “Science in Motion: Common Molecular Pathological Themes Emerge in the Hereditary Spastic Paraplegias,”J. Med. Genet.40: 81-86 (2003).
Scott, W.K. et al., “Locus Heterogeneity, Anticipation and Reduction of the Chromosome 2p Minimal Candidate Region in Autosomal Dominant Familial Spastic Paraplegia,”Neurogenetics, 1:95-102 (1997).
Svenson, I.K., et al., “Identification and Expression Analysis of Spastin Gene Mutations in Hereditary Spastic Paraplegia,”Am. J. Hum. Genet. 68:1077-1085 (2001).
Svenson, I.K., et al., Intragenic Modifiers of Hereditary Spastic Paraplegia Due to Spastin Gene Mutations,Neurogenetics5:157-164 (2004).
Tallaksen, C.M.E., et al., “Recent Advances in Hereditary Spastic Paraplegia,”Curr. Opinion in Neurology, 14:457-463 (2001).
Züchner, S., et al. “A New Locus for Dominant Hereditary Spastic Paraplegia Maps to Chromosome 2p12,”Neurogenetics, 7:127-129 (2006).
Züchner, S., et al. “Mutations in the Novel Mitochondrial Protein REEP1 Cause Hereditary Spastic Paraplegia Type 31”Am. J. Hum. Genet. 79:365-369 (2006).
Zhao, X., et al. “Mutations in a Newly Identified GTPase Gene Cause Autosomal Dominant Hereditary Spastic Paraplegia,”Nature Genetics, 29: 326-331 (2001).
Finsterer, J., “Hereditäre Spastische Paraplegien,”Nervenarzt, 74:497-504 (2003).
Saito, H., et al., “RTP Family Members Induce Functional Expression of Mammalian Odorant Receptors,”Cell, 119:679-691 (2004).
Database SNPDB, NCBI: “Single Nucleotide Polymorphism,” Accession No. rs3087642 (2002).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Identification of a novel gene underlying familial spastic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Identification of a novel gene underlying familial spastic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Identification of a novel gene underlying familial spastic... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4161759

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.